MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 25, 2009; DOI: 10.1124/mol.109.056176


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.109.056176v1
76/3/652    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Lopez-Hernandez, G. Y
Right arrow Articles by Papke, R. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez-Hernandez, G. Y
Right arrow Articles by Papke, R. L


Received for publication March 13, 2009.
Revised June 23, 2009.
Accepted for publication June 25, 2009.

Selective inhibition of acetylcholine-evoked responses of {alpha}7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists

Gretchen Y Lopez-Hernandez 1, Jeffrey S Thinschmidt 1, Guangrong Zheng 2, Zhenfa Zhang 2, Peter A Crooks 2, Linda P. Dwoskin 2, Roger L Papke 1*

1 University of Florida 2 University of Kentucky

* Address correspondence to: E-mail: rlpapke{at}ufl.edu

Abstract

A family of twenty tris-azaaromatic quaternary ammonium (AQA) compounds were tested for their inhibition of {alpha}7 nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes. The potency of inhibitory activity was related to the hydrophobic character of the tris head groups. Two tris-AQA compounds were studied in detail: the highly effective inhibitor, tPyQB, and the less potent antagonist, tPy2PiB. Additionally, we evaluated tkP3BzPB, a tetrakis-AQA with very hydrophobic headgroups. We compared the activity of the AQA compounds to the frequently used {alpha}7-antagonist methyllycaconitine (MLA). Both tPyQB and tkP3BzPB were selective antagonists of {alpha}7. However, while inhibition by tPyQB was reversible within 5 min, the recovery time constant for tkP3BzPB inhibition was 26.6 ± 0.8 min, so that the equilibrium inhibition in the prolonged presence of nanomolar concentrations of tkP3BzPB was nearly 100%. The potency, selectivity, and slow reversibility of tkP3BzPB were comparable to or greater than that of MLA. The inhibitory actions of tPyQB, tPy2PiB, and tkP3BzPB were evaluated on the acetylcholine (ACh)-evoked responses of native nAChRs in rat brain slices. The {alpha}7-mediated responses of hippocampal interneurons were effectively reduced by 1 µM tPyQB and tkP3BzPB, but not tPy2PiB. In rat medial septum, tkP3BzPB produced a greater inhibition of ACh-evoked responses of cells with fast inward currents (Type I) than of cells with predominantly slow kinetics (Type II), suggesting that tkP3BzPB can block {alpha}7 yet preserve the responsiveness of non- {alpha}7 receptors. These agents might be helpful in elucidating complex receptor responses in brain regions with mixed populations of nAChRs.


Key words: Nicotinic cholinergic, Structure-activity relationships and modeling, Func. analysis receptor/ion channel mutants, Receptor-mediated





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2009 by the American Society for Pharmacology and Experimental Therapeutics